The Korean Journal of Nuclear Medicine (대한핵의학회지)

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Development of Dual Reporter System of Mutant Dopamine 2 Receptor ($D_2R$) and Sodium Iodide Symporter (NIS) Transgenes

변이 도파민 2 수용체와 나트륨 옥소 공동 수송체 이입유전자의 이중 리포터시스템 개발

  • Hwang, Do-Won (Program in Neuroscience, Seoul National University) ;
  • Lee, Dong-Soo (Program in Neuroscience, Seoul National University) ;
  • Kang, Joo-Hyun (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Chang, Young-Soo (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Kim, Yun-Hui (Program in Neuroscience, Seoul National University) ;
  • Jeong, Jae-Min (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Chung, June-Key (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Lee, Myung-Chul (Department of Nuclear Medicine, Seoul National University College of Medicine)
  • 황도원 (서울대학교 뇌과학 협동과정) ;
  • 이동수 (서울대학교 뇌과학 협동과정) ;
  • 강주현 (서울대학교 의과대학 핵의학교실) ;
  • 장영수 (서울대학교 의과대학 핵의학교실) ;
  • 김윤희 (서울대학교 뇌과학 협동과정) ;
  • 정재민 (서울대학교 의과대학 핵의학교실) ;
  • 정준기 (서울대학교 의과대학 핵의학교실) ;
  • 이명철 (서울대학교 의과대학 핵의학교실)
  • Published : 2004.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Both human NIS and mutant $D_2R$ transgenes are proposed as reporting system in transplanted cell tracking. Using hepatoma cell lines, we constructed a dual reporter system containing human sodium-iodide symporter (hNIS) and dopamine 2 receptor ($D_2R$) and compared its characteristics. Materials and Methods: The recombinant plasmid ($pIRES-hNIS/D_2R$) was constructed with IRES (internal ribosome entry site) under control of the CMV promoter $pIRES-hNIS/D_2R$ was transfected to human hepatoma SK-Hep1 cell line with lipofectamine. HEP-ND ($SK-Hep1-hNIS/D_2R$) cells stably expressing hNIS and $D_2R$ was established by selection with G418 for two weeks. RT-PCR was performed to investigate the expression of both hNIS and $D_2R$ genes. The expressions of hNIS and $D_2R$ were measured by $^{125}I$ uptake assays and receptor binding assays. Specific binding of $D_2R$ to $[^3H]spiperone$ was verified by Scatchard plot with (+) butaclamol as a specific inhibitor. $K_d\;and\;B_{max}$ values were estimated. The correlation between hNIS and $D_2R$ expression was compared by using each clone. Results: Similar quantities of hNIS and $D_2R$ genes were expressed on HEP-ND as RT-PCR assays. HEP-ND cells showed 30 to 40 fold higher radioiodine uptakes than those of parental SK-Hep1 cells. $^{125}I$ uptake in HEP-ND cells was completely inhibited by $KClO_4$, a NIS inhibitor Specific binding to HEP-ND cells was saturable and the $K_d\;and\;B_{max}$ values for HEP-ND cells were 2.92 nM, 745.25 fmol/mg protein and 2.91nM, 1323 fmole/mg protein in two clones, respectively. The radioiodine uptake by hNIS activity and $D_2R$ binding was highly correlated. Conclusion: We developed a dual positron and gamma imaging reporter system of hNIS and $D_2R$ in a stably transfected cell line. We expect that $D_2R$ and hNIS genes can complement mutually as a nuclear reporting system or that $D_2R$ can be used as reporter gene when hNIS gene were used as a treatment gene.

목적 : 현재 생체 내로 이식된 세포를 추적하는데 여러 가지 리포터 유전자들이 이용되고 있다. 이 연구에서는 사람 나트륨 옥소 공동 수송체 (hNIS)와 도파민 2 수용체($D_2R$)를 이중 리포터 유전자로 사용하여 각각을 비교하였다. 대상 및 방법: hNIS와 $D_2R$의 발현이 동시에 이루어지도록 하기 위해서 IRES (Internal ribosome entry site)로 연결된 재조합 플라스미드(pIRES-hNIS/D_2R)를 제조하였다. $pIRES-hNIS/D_2R$를 사람의 간암세포주인 SK-Hep1에 lipofactamine을 이용하여 형질을 도입시킨 후, 항생제(G418)를 농도별로 처리하여 2주간 선별하였다(HEP-ND). hNIS와 $D_2R$발현 유무와 발현 정도를 알아보기 위하여 각 유전자에 특이적인 프라이머를 이용하여 RT-PCR을 수행하였다. 각 형질 도입세포군에서, hNIS의 활성은 $^{125}I$ 섭취율을 이용하여 측정하고 $D_2R$의 활성은 $[^3H]spiperone$을 리간드로 이용하여 수용체 결합 정도를 측정하였다. 결과: 선별된 HEP-ND세포에서 hNIS와 $D_2R$의 발현을 RT-PCR로 확인하였을 때 IRES로 연결된 hNIS와 $D_2R$의 발현 정도는 서로 비슷하였다. HEP-ND세포의 $^{125}I$ 섭취율은 대조군인 SK-Hep1세포에 배해 30-40배 증가되었고, $KClO_4$에 의해 $^{125}I$ 섭취가 저해되었다. $D_2R$의 발현 정도를 측정할 수 있는 수용체 결합 분석법을 통해G418 농도별로 나눈 두 종류의 세포주에서, $[^3H]spiperone$을 이용한 해리상수 ($K_d$)와 최대결합 부위농도 ($B_{max}$)는 각각 2.92 nM, 745.25 fmol/mg protein과 8.91nM, 1323 fmole/mg protein이었다. hNIS와 $D_2R$발현의 상관관계에서는 높은 상관관계를 나타내었다. 결론: 이 연구에서 hNIS와 $D_2R$가 이입된 세포주에서 이중 유전자, 감마 영상 리포터 시스템을 개발하였으며, $D_2R$와 HNIS 유전자를 이중 핵 영상 시스템으로서 서로 상호보완적으로 이용할 수 있을 것으로 기대하고 있다.

Keywords

References

  1. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol 1999;26:481-90 https://doi.org/10.1016/S0969-8051(99)00021-9
  2. Herschman HR, MacLaren DC, Iyer M, Namavari M, Bobinski K, Green LA, et al. Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. Neurosci Res 2000;15:699-705
  3. Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 2002;43:1188-200
  4. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-60 https://doi.org/10.1038/379458a0
  5. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998;78:189-225 https://doi.org/10.1152/physrev.1998.78.1.189
  6. Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M,etal. Cloning and expression of a rat D2 receptor cDNA. Nature 1988;336:783-7 https://doi.org/10.1038/336783a0
  7. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T,etal. Repetitive, non-invasive imaging of the dopamine $D_2$ receptor as a reporter gene in living animals. Gene Thrapy 1999;6:785-91 https://doi.org/10.1038/sj.gt.3300877
  8. Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps MP. Noninvasive, quantitative imaging in living animals of a mutant dopamine $D_2$ receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Thrapy 2001;8:1490-98 https://doi.org/10.1038/sj.gt.3301542
  9. Gurtu V, Yan G, Zhang G. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines. Biochem Biophys Res Commun 1996;229:295-8 https://doi.org/10.1006/bbrc.1996.1795
  10. Min JJ, Chung JK, Lee YJ, Shin JH, Yeo JS, Jeong JM, et al. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002;29:537-45 https://doi.org/10.1016/S0969-8051(02)00304-9
  11. Barrio JR, Satyamurthy N, Huang SC, Keen RE, Nissenson CH, Hoffman JM, et al. 3-(2'-[$^{18}F$]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cereb Blood Flow Metab 1989;9:830-9 https://doi.org/10.1038/jcbfm.1989.117
  12. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with $^{64}Cu$-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 2002;99:3030-5 https://doi.org/10.1073/pnas.052709599
  13. Shin JH, Chung JK, Kang JH, Lee YJ, Kim KI, Kim CW. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk. Eur J Nucl Med Mol Imaging 2004;31:425-32 https://doi.org/10.1007/s00259-003-1394-8
  14. Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Namavari M, et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Thrapy 2001;8:1072-80 https://doi.org/10.1038/sj.gt.3301490
  15. Sun X, Annala AJ, Yaghoubi SS, Barrio JR, Nguyen KN, Toyokuni T, et al. Quantitative imaging of gene induction in living animals. Gene Thrapy 2001;8:1572-9 https://doi.org/10.1038/sj.gt.3301554
  16. Woodward R, Coley C, Daniell S, Naylor LH, Strange PG. Investigation of the role of conserved serine residues in the long form of the rat D2 dopamine receptor using site-directed mutagenesis. J Neurochem 1996;66:394-402 https://doi.org/10.1046/j.1471-4159.1996.66010394.x
  17. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nature Medicine 2000;6:933-7 https://doi.org/10.1038/78704
  18. Palacios JM, Niehoff DS, Kuhar MJ. [$^3H$]spiperone binding sites in brain: Autoradiographic localization of multiple receptors. Brain Research 1981;213:277-89
  19. Vile JM, D'Souza UM, Strange PG. [$^3H$]nemonapride and [$^3H$]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions. J Neurochem 1995;64:940-3 https://doi.org/10.1046/j.1471-4159.1995.64020940.x
  20. Bahn MM, Huang SC, Hawkins RA, Satyamurthy N, Hoffman JM, Barrio JR, et al. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[$^{18}F$]fluoroethyl)spiperone examined with positron emission tomography. J Cereb Blood Flow Metab 1989;9:840-9 https://doi.org/10.1038/jcbfm.1989.118
  21. Satyamurthy N, Barrio JR, Bida GT, Huang SC, Mazziotta JC, Phelps ME. 3-(2'-[$^{18}F$]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Int J Rad Appl Instrum 1990;41:113-29 https://doi.org/10.1016/0883-2889(90)90096-Y